Related Experiment Video
Updated: Jun 11, 2026
09:47
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
Published on: May 25, 2018
Selective detection of Cathepsin E proteolytic activity.
Wael R Abd-Elgaliel1, Ching-Hsuan Tung
1Department of Radiology, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, TX, USA.
Biochimica Et Biophysica Acta
|July 6, 2010
Summary
Researchers developed a new fluorogenic peptide substrate that selectively detects Cathepsin E (Cath E) activity, distinguishing it from Cathepsin D (Cath D). This advancement aids in understanding protease roles and developing Cath E-specific inhibitors.
Area of Science:
- Biochemistry
- Enzymology
- Protease research
Background:
- Cathepsin E (Cath E) and Cathepsin D (Cath D) are aspartic proteases with similar characteristics.
- Elucidating their substrate specificity is crucial for defining their distinct biological roles.
Purpose of the Study:
- To develop a novel peptide-substrate that is selectively cleaved by Cath E but not by Cath D.
- To establish a reliable method for measuring Cath E proteolytic activity.
Main Methods:
- A fluorogenic peptide substrate (Mca-Ala-Gly-Phe-Ser-Leu-Pro-Ala-Lys(Dnp)-DArg-CONH₂) was synthesized.
- The substrate utilizes intramolecular fluorescence quenching, which is relieved upon cleavage.
- Proteolytic activity was assessed by measuring fluorescence changes upon incubation with different cathepsins.
Main Results:
- The developed substrate demonstrated a 265-fold greater fluorescence signal with Cath E compared to Cath D.
- Cleavage specificity was confirmed to be at the Leu-Pro bond by LC-MS.
- Cath E exhibited a catalytic efficiency (Kcat/Km) of 16.7 μM⁻¹s⁻¹ for the substrate, while Cath D showed no measurable activity.
Conclusions:
- The novel fluorogenic substrate is a promising tool for selective measurement of Cath E proteolytic activity.
- This work lays the groundwork for developing specific inhibitors targeting Cath E.
